Skip to main content
. 2016 May 6;5(5):e003221. doi: 10.1161/JAHA.116.003221

Figure 2.

Figure 2

Tornado diagrams on (A) incremental cost and (B) incremental QALYs comparing the relative importance of model parameters for ivabradine vs background therapy. CV indicates cardiovascular; HF, heart failure; QALY, quality‐adjusted life year.